Back to Search
Start Over
Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes
- Source :
- The Lancet Diabetes & Endocrinology vol.8 (2020) nr.6 p.470-472
- Publication Year :
- 2020
Details
- Database :
- OAIster
- Journal :
- The Lancet Diabetes & Endocrinology vol.8 (2020) nr.6 p.470-472
- Notes :
- DOI: 10.1016/S2213-8587(20)30104-2, The Lancet Diabetes & Endocrinology vol.8 (2020) nr.6 p.470-472, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1228901334
- Document Type :
- Electronic Resource